Effect of nitric-oxide synthesis on tumour blood volume and vascular activity: a phase I study.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  The Lancet Oncology

• Publication date

  2007-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S1470-2045(07)70001-3PMID 17267325
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantitative assessment of lung cancer perfusion using MDCT: does measurement reproducibility improve with greater tumor volume coverage?

  2006cited by this paper
• Quantitative assessment of tissue perfusion using MDCT: comparison of colorectal cancer and skeletal muscle measurement reproducibility.

  2006cited by this paper
• Roles of Nitric Oxide Synthase Inhibition and Vascular Endothelial Growth Factor Receptor-2 Inhibition on Vascular Morphology and Function in an In vivo Model of Pancreatic Cancer

  2006cited by this paper
• The role of nitric oxide in tumour progression

  2006cited by this paper
• Lung cancer perfusion at multi-detector row CT: reproducibility of whole tumor quantitative measurements.

  2006cited by this paper
• Correlation between initial and early follow-up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ-preservation therapy.

  2006cited by this paper
• Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

  2004cited by this paper
• Solitary pulmonary nodules: dynamic enhanced multi-detector row CT study and comparison with vascular endothelial growth factor and microvessel density.

  2004cited by this paper
• Perfusion CT in patients with advanced bronchial carcinomas: a novel chance for characterization and treatment monitoring?

  2004cited by this paper
• Quantitative Evaluation of Perfusion and Permeability of Peripheral Tumors Using Contrast-Enhanced Computed Tomography

  2004cited by this paper
• Nitric oxide in cancer and chemoprevention.

  2003cited by this paper
• Is inducible nitric oxide synthase a target for chemoprevention?

  2003cited by this paper
• Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice.

  2003cited by this paper
• Effects of overexpression of dimethylarginine dimethylaminohydrolase on tumor angiogenesis assessed by susceptibility magnetic resonance imaging.

  2003cited by this paper
• Perfusion CT for the assessment of tumour vascularity: which protocol?

  2003cited by this paper
• Lung Tumors Evaluated With FDG-PET and Dynamic CT: The Relationship Between Vascular Density and Glucose Metabolism

  2002cited by this paper
• Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability

  2001cited by this paper
• Role of nitric oxide in carcinogenesis and tumour progression.

  2001cited by this paper
• Nitric oxide synthases: structure, function and inhibition.

  2001cited by this paper
• Double-Phase Helical CT of Small Renal Parenchymal Neoplasms: Correlation with Pathologic Findings and Tumor Angiogenesis

  2000cited by this paper
• Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas.

  2000cited by this paper
• Regulation of angiogenesis via vascular endothelial growth factor receptors.

  2000cited by this paper
• Imaging of tumour therapy responses by dynamic CT.

  1999cited by this paper
• CT measurement of perfusion and permeability within lymphoma masses and its ability to assess grade, activity, and chemotherapeutic response.

  1999cited by this paper
• Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer.

  1998cited by this paper
• Selective expression of inducible nitric oxide synthase in human prostate carcinoma

  1998cited by this paper
• Nitric oxide synthase modulates angiogenesis in response to tissue ischemia.

  1998cited by this paper
• Nitric Oxide Synthase Activity in Human Lung Cancer

  1997cited by this paper
• Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells.

  1997cited by this paper
• Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis.

  1997cited by this paper
• Role of nitric oxide in tumor microcirculation. Blood flow, vascular permeability, and leukocyte-endothelial interactions.

  1997cited by this paper
• Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine.

  1997cited by this paper
• Quantitative Imaging in Oncology

  1996cited by this paper
• Reversed-phase high-performance liquid chromatography method for the analysis of nitro-arginine in rat plasma and urine.

  1996cited by this paper
• NG-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin 2-induced capillary leakage and reduces tumour growth in adenocarcinoma-bearing mice.

  1996cited by this paper
• Expression of nitric oxide synthase in human central nervous system tumors.

  1995cited by this paper
• Roles of nitric oxide in tumor growth.

  1995cited by this paper
• Nitric oxide synthase activity in human gynecological cancer.

  1994cited by this paper
• Inhibition of nitric oxide synthesis increases blood pressure in healthy humans

  1993cited by this paper
• L‐arginine pathway in the sepsis syndrome

  1993cited by this paper
• Nitric oxide: physiology, pathophysiology, and pharmacology.

  1991cited by this paper
• Modification of tumour blood flow--a review.

  1991cited by this paper
• Nitric oxide: an endogenous modulator of leukocyte adhesion.

  1991cited by this paper
• Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy.

  1990cited by this paper
• THE PERMEABILITY OF CAPILLARIES IN VARIOUS ORGANS AS DETERMINED BY USE OF THE 'INDICATOR DIFFUSION' METHOD.

  1963cited by this paper
• Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles.

  1959cited by this paper

• Improving the Efficacy of Common Cancer Treatments via Targeted Therapeutics towards the Tumour and Its Microenvironment

  2024cites this paper
• Biopterin metabolism and nitric oxide recoupling in cancer

  2024cites this paper
• Effects of Dietary Glycinin on Oxidative Damage, Apoptosis and Tight Junction in the Intestine of Juvenile Hybrid Yellow Catfish, Pelteobagrus fulvidraco ♀ × Pelteobaggrus vachelli ♂

  2022cites this paper
• Application of Radiosensitizers in Cancer Radiotherapy

  2021cites this paper
• Camelid Single-Domain Antibodies for Targeting Cancer Nanotheranostics

  2021cites this paper
• Protective role of natural products in glioblastoma multiforme: A focus on nitric oxide pathway.

  2020cites this paper
• The Yin Yang Role of Nitric Oxide in Prostate Cancer

  2020cites this paper
• Nitric Oxide in Hematological Cancers: Partner or Rival?

  2020cites this paper
• Physiopathology of nitric oxide in the oral environment and its biotechnological potential for new oral treatments: a literature review

  2020cites this paper
• Small molecule inhibition of DDAH1 significantly attenuates triple negative breast cancer cell vasculogenic mimicry in vitro.

  2019cites this paper
• Volume Computed Tomography Perfusion Imaging: Evaluation of the Significance in Oncologic Follow-up of Metastasizing Renal Cell Carcinoma in the Early Period of Targeted Therapy — Preliminary Results

  2019influential citation
• Fine-Tuning Tumor Endothelial Cells to Selectively Kill Cancer

  2017cites this paper
• Nitric Oxide Synthase in Male Urological and Andrologic Functions

  2017cites this paper
• Quantitative Assessment of the Effect of Nitric Oxide Synthase Inhibition on Tumor Vascular Activity Using Dynamic Contrast-Enhanced Computed Tomography

  2016cites this paper
• Nitric Oxide Synthase Uncoupling in Tumor Progression and Cancer Therapy

  2016cites this paper
• Differential diagnostic value of computed tomography perfusion combined with vascular endothelial growth factor expression in head and neck lesions

  2016cites this paper
• Investigating the role of tumour cell derived iNOS on tumour growth and vasculature in vivo using a tetracycline regulated expression system

  2016cites this paper
• Gasotransmitters in cancer: from pathophysiology to experimental therapy

  2015cites this paper
• Perfusion CT imaging of treatment response in oncology.

  2015cites this paper
• NO to cancer: The complex and multifaceted role of nitric oxide and the epigenetic nitric oxide donor, RRx-001☆

  2015cites this paper
• Targeting Hyponitroxia in Cancer Therapy

  2015cites this paper
• NOS Inhibition Modulates Immune Polarization and Improves Radiation-Induced Tumor Growth Delay.

  2015cites this paper
• Infantile Hemangiomas, Retinopathy of Prematurity and Cancer: A Common Pathogenetic Role of the β‐Adrenergic System

  2015cites this paper
• Gr-1+CD11b+ cells facilitate Lewis lung cancer recurrence by enhancing neovasculature after local irradiation

  2014cites this paper
• The Implications of Hyponitroxia in Cancer

  2014influential citation
• Imaging Assessment of Lung Tumor Angiogenesis: Insights and Innovations

  2014cites this paper
• The Endothelial ADMA/NO Pathway in Hypoxia-Related Chronic Respiratory Diseases

  2014cites this paper
• Hypertension During Vascular Endothelial Growth Factor Inhibition: Focus on Nitric Oxide, Endothelin-1, and Oxidative Stress

  2014cites this paper
• The acute physiological effects of the vaso-active drug, L-NNA, a nitric oxide synthase inhibitor, on renal and tumour perfusion in human subjects

  2014cites this paper
• iNOS: a potential therapeutic target for malignant glioma.

  2013cites this paper
• CT perfusion in oncologic imaging: a useful tool?

  2013cites this paper
• The yin and yang of nitric oxide in cancer progression.

  2013cites this paper
• A Phase 1 dose-finding and pharmacodynamic study of rapamycin in combination with bevacizumab in patients with unresectable hepatocellular carcinoma.

  2013cites this paper
• Targeting the Tumour Vasculature: Exploitation of Low Oxygenation and Sensitivity to NOS Inhibition by Treatment with a Hypoxic Cytotoxin

  2013cites this paper
• Increased expression of activated endothelial nitric oxide synthase contributes to antiandrogen resistance in prostate cancer cells by suppressing androgen receptor transactivation.

  2013cites this paper
• Development of a dynamic quality assurance testing protocol for multisite clinical trial DCE-CT accreditation.

  2013cites this paper
• Rapid decrease in delivery of chemotherapy to tumors after anti-VEGF therapy: implications for scheduling of anti-angiogenic drugs.

  2012cites this paper
• Dynamic Contrast-Enhanced Computed Tomography in Metastatic Nasopharyngeal Carcinoma: Reproducibility Analysis and Observer Variability of the Distributed Parameter Model

  2012cites this paper
• Current status and guidelines for the assessment of tumour vascular support with dynamic contrast-enhanced computed tomography

  2012cites this paper
• Studies of Protein S-nitrosylation in Prostate Cancer focused on Integrin Alpha 6, Proliferating Cell Nuclear Antigen and Estrogen Receptor Beta

  2012cites this paper
• Aspects of perfusion quantification using contrast-enhanced ultrasound within the clinical context of colorectal liver metastases

  2012cites this paper
• Is Nitric Oxide (NO) the Last Word in Radiosensitization? A Review.

  2012cites this paper
• Computed tomography perfusion imaging for therapeutic assessment: has it come of age as a biomarker in oncology?

  2012cites this paper
• Management of advanced non-small cell lung cancer: moving towards a more personalised approach

  2012cites this paper
• Operable non-small cell lung cancer: correlation of volumetric helical dynamic contrast-enhanced CT parameters with immunohistochemical markers of tumor hypoxia.

  2012cites this paper
• Radiohalogenated nonnatural amino acids as PET and SPECT tumor imaging agents

  2012cites this paper
• Testosterone and prolactin increase carboxypeptidase‐D and nitric oxide levels to promote survival of prostate cancer cells

  2012cites this paper
• Beyond antiangiogenesis: vascular modulation as an anticancer therapy-a review.

  2012influential citation
• The Microenvironment of Ovarian Cancer: Lessons on Immune Mediated Tumor Rejection or Tolerance

  2011cites this paper
• Nitric Oxide Synthase Inhibition Enhances the Antitumor Effect of Radiation in the Treatment of Squamous Carcinoma Xenografts

  2011cites this paper
• The challenges of integrating molecular imaging into the optimization of cancer therapy.

  2011cites this paper
• Six degrees of separation: the oxygen effect in the development of radiosensitizers.

  2011cites this paper
• Radiation dose from volumetric helical perfusion CT of the thorax, abdomen or pelvis

  2011cites this paper
• Collagen IV contributes to nitric oxide-induced angiogenesis of lung endothelial cells.

  2011cites this paper
• The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis

  2011cites this paper
• COPD as an independent risk factor for lung cancer in patients with bronchial squamous dysplasia

  2011cites this paper
• Eficacia de la suplementación con L-arginina sobre la respuesta a la quimioterapia neoadyuvante en pacientes con cáncer de mama

  2011cites this paper
• Inhibitory effects of fruit extracts on nitric oxide- induced proliferation in MCF-7 cells.

  2011cites this paper
• Dinitrosyl Iron Complexes and their Role in Patho-physiological Conditions

  2011cites this paper
• angiogenesis of lung endothelial cells Collagen IV contributes to nitric oxide-induced

  2011cites this paper
• The role of tumour-derived iNOS in tumour progression and angiogenesis

  2010cites this paper
• Oxidative and Nitrosative Stress in the Metastatic Microenvironment

  2010cites this paper
• Why does diabetes offer protective effects against prostate cancer? The possible role of its microvascular complications.

  2010cites this paper
• Sensitizing Effect of Nitric Oxide to Cytotoxic Stimuli

  2010cites this paper
• Nitric oxide in cancer therapeutics: interaction with cytotoxic chemotherapy.

  2010cites this paper
• Molecular imaging with dynamic contrast-enhanced computed tomography.

  2010cites this paper
• Assessment of non-small cell lung cancer perfusion: pathologic-CT correlation in 15 patients.

  2010cites this paper
• Nitrosative stress as a mediator of apoptosis: implications for cancer therapy.

  2010cites this paper
• Role of Nitric Oxide for Modulation of Cancer Therapy Resistance

  2010cites this paper
• CT perfusion in oncology: how to do it

  2010cites this paper
• Quantitative helical dynamic contrast enhanced computed tomography assessment of the spatial variation in whole tumour blood volume with radiotherapy in lung cancer.

  2010cites this paper
• Nitric Oxide: Perspectives and Emerging Studies of a Well Known Cytotoxin

  2010influential citation
• Roles of tetrahydrobiopterin in promoting tumor angiogenesis.

  2010cites this paper
• Targeting the tumour microenvironment : characterizing the anti-vascular effects of the hypoxic cytotoxin tirapazamine

  2010cites this paper
• Metastatic renal carcinoma: evaluation of antiangiogenic therapy with dynamic contrast-enhanced CT.

  2010cites this paper
• Roles of Tetrahydrobiopterin in Promoting Tumor

  2010cites this paper
• Donepezil, an acetylcholinesterase inhibitor against Alzheimer's dementia, promotes angiogenesis in an ischemic hindlimb model.

  2010cites this paper
• Angiogenesis in non-small cell lung cancer: imaging with perfusion computed tomography.

  2010cites this paper
• Vascular Disruptive Agents in Combination with Radiotherapy

  2010cites this paper
• Therapeutic Applications of Nitric Oxide for Malignant Tumor in Animal Models and Human Studies

  2010influential citation
• Comprehensive Identification and Modified-Site Mapping of S-Nitrosylated Targets in Prostate Epithelial Cells

  2010cites this paper
• Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?

  2010cites this paper
• Nitric oxide delivery to cancer: why and how?

  2009cites this paper
• Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivin

  2009cites this paper
• Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and in inflammation--a tale of three gases!

  2009cites this paper
• Assessment of the spatial pattern of colorectal tumour perfusion estimated at perfusion CT using two-dimensional fractal analysis

  2009cites this paper
• Endothelin B Receptor, a New Target in Cancer Immune Therapy

  2009cites this paper
• Synthesis of novel methotrexate derivatives with inhibition activity of nitric oxide synthase

  2009cites this paper
• Nitric Oxide Synthase Inhibition Enhances the Tumor Vascular-Damaging Effects of Combretastatin A-4 3-O-Phosphate at Clinically Relevant Doses

  2009cites this paper
• Development of a method to quantitatively monitor the effect of inhibition of nitric oxide synthase on tumour vascular activity using dynamic contrast-enhanced computed tomography

  2009cites this paper
• Production of Nitric Oxide and Expression of Inducible Nitric Oxide Synthase in Ovarian Cystic Tumors

  2009cites this paper
• Molecular regulation of tumour angiogenesis by nitric oxide.

  2009cites this paper
• Nitric oxide synthase gene polymorphisms and prostate cancer risk.

  2009cites this paper
• Biomarker-Driven Early Clinical Trials in Oncology: A Paradigm Shift in Drug Development

  2009cites this paper
• Thrombospondin 1 and vasoactive agents indirectly alter tumor blood flow.

  2008cites this paper
• Quantitative assessment of colorectal cancer tumor vascular parameters by using perfusion CT: influence of tumor region of interest.

  2008cites this paper
• Effect of temporal interval between scan acquisitions on quantitative vascular parameters in colorectal cancer: implications for helical volumetric perfusion CT techniques.

  2008cites this paper
• Clinical biomarkers of angiogenesis inhibition

  2008cites this paper
• Colorectal tumor vascularity: quantitative assessment with multidetector CT--do tumor perfusion measurements reflect angiogenesis?

  2008cites this paper
• Nitric oxide and the collagenous protein biosynthesis of irradiated chick chorioallantoic membrane.

  2008cites this paper